Joyzyme Group Limited (HKG:8622)
Hong Kong · Delayed Price · Currency is HKD 0.1770
+0.0180 (11.32%)
Jul 31, 2026, 1:02 PM HKT
Joyzyme Group Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 28.28 | 28.28 | 25.36 | 24.63 | 25.33 | 26.13 |
Revenue Growth | 9.75% | 11.53% | 2.96% | -2.77% | -3.05% | 18.94% |
Gross Profit Gross Profit Growth | 17.77 | 17.77 | 17.07 | 16.09 | 16.91 | 16.46 |
Operating Income Operating Income Growth | -7.89 | -7.89 | -5.01 | -6.71 | -4.7 | -4.32 |
Net Income Net Income Growth | -5.01 | -5.01 | -4.16 | -5.78 | -3.08 | -4.22 |
Earnings Per Share EPS Growth | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Biological Reagents and Auxiliary Reproductive Supplies and Equipments Biological Reagents and Auxiliary Reproductive Supplies and Equipments Growth | 25.53 | 25.53 | 25.36 | 24.31 | 23.18 | 23.33 |
Healthcare Products and Supplements Healthcare Products and Supplements Growth | 2.75 | 2.75 | - | 0.32 | 2.15 | 2.8 |
Total Total Growth | 28.28 | 28.28 | 25.36 | 24.63 | 25.33 | 26.13 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 41.94 | 41.94 | 36.5 | 32.94 | 33.3 | 36.21 |
Total Debt Total Debt Growth | 5.96 | 5.96 | 4.08 | 5.14 | 1.88 | 1.79 |
Net Cash (Debt) Net Cash Growth | 35.98 | 35.98 | 32.41 | 27.8 | 31.43 | 34.42 |
Net Cash Growth | 10.44% | 11.00% | 16.59% | -11.54% | -8.70% | -12.42% |
Net Cash Per Share Net Cash Per Share Growth | 0.07 | 0.07 | 0.07 | 0.07 | 0.08 | 0.09 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -2.79 | -2.79 | -3.06 | -0.05 | 1.29 | -2.38 |
Capital Expenditures CapEx Growth | -1.11 | -1.11 | -1.99 | -1.5 | -0.65 | -1.95 |
Free Cash Flow Free Cash Flow Growth | -3.9 | -3.9 | -5.05 | -1.55 | 0.64 | -4.33 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 62.83% | 62.83% | 67.32% | 65.34% | 66.77% | 62.98% |
Operating Margin | -27.90% | -27.90% | -19.76% | -27.26% | -18.54% | -16.52% |
Pretax Margin | -17.73% | -17.73% | -16.40% | -23.48% | -11.87% | -14.94% |
Profit Margin | -17.70% | -17.70% | -16.40% | -23.48% | -12.14% | -16.15% |
FCF Margin | -13.78% | -13.78% | -19.93% | -6.29% | 2.51% | -16.57% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
P/FCF Ratio | - | - | - | - | 106.48 | - |
PS Ratio | 2.92 | 7.13 | 2.78 | 1.65 | 2.68 | 3.09 |